They provide customized scientific models for testing new therapeutics in the treatment of various illnesses, including breast cancer, lung cancer, prostate cancer, arthritis, and COPD. Their services range from in vitro studies to in vivo target engagement, tailored to meet the specific needs of their global clients, which include pharmaceutical and biotech companies, research organizations, and virtual/semi-virtual development firms. Axis Bio also offers expertise in animal models for inflammatory diseases and oncology, with partnerships that allow them to provide a wide range of preclinical services.